oasis 3 semaglutide 50 mg of oral #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj Semaglutide as a GLP-1 Agonist:

When youve exhausted the options within a single-receptor medication, adding a second receptor pathway through tirzepatide gives your body a genuinely new stimulus to respond to

Over several weeks or months, your provider may gradually increase the dose

This reduction in potency may mean that the medication does not provide the expected blood sugar management or weight loss benefits, which could be problematic for patients relying on consistent results

Because GLP-1 medications are highly effective at promoting weight loss, some of the observed benefit may be related to weight reduction

The reconstitution technique itself determines whether your semaglutide maintains full potency or degrades before you even draw your first dose